The dominant logic of Big Tech in healthcare and pharma
dc.contributor.author
Schuhmacher, Alexander
dc.contributor.author
Haefner, Naomi
dc.contributor.author
Honsberg, Katharina
dc.contributor.author
Goldhahn, Jörg
dc.contributor.author
Gassmann, Oliver
dc.date.accessioned
2023-04-20T07:22:21Z
dc.date.available
2023-01-04T04:58:03Z
dc.date.available
2023-04-20T07:22:21Z
dc.date.issued
2023-02
dc.identifier.issn
1359-6446
dc.identifier.issn
1878-5832
dc.identifier.other
10.1016/j.drudis.2022.103457
en_US
dc.identifier.uri
http://hdl.handle.net/20.500.11850/589992
dc.description.abstract
Digital health and digital pharma are considered supportive tools for patients and healthcare providers (HCPs), making the market highly attractive for industry players. Not surprisingly, Tech Giants have started to move into this area. We utilized established management models and publicly available information sources, such as annual company reports, and performed a thorough analysis to uncover the underlying business models of Alphabet, Amazon, Apple, IBM, and Microsoft in order to better understand their intention and course of entering the healthcare and pharma industries. Our results indicate that Big Tech or Tech Giants do address the needs of patients and physicians, while having built clear value propositions, value chains, and revenue models to sustainably revolutionize the healthcare and pharma industries.
en_US
dc.language.iso
en
en_US
dc.publisher
Elsevier
en_US
dc.subject
Big Tech
en_US
dc.subject
digital
en_US
dc.subject
healthcare
en_US
dc.subject
pharma
en_US
dc.subject
business model
en_US
dc.title
The dominant logic of Big Tech in healthcare and pharma
en_US
dc.type
Other Journal Item
dc.date.published
2022-11-24
ethz.journal.title
Drug Discovery Today
ethz.journal.volume
28
en_US
ethz.journal.issue
2
en_US
ethz.journal.abbreviated
Drug Discov. Today
ethz.pages.start
103457
en_US
ethz.size
8 p.
en_US
ethz.identifier.wos
ethz.identifier.scopus
ethz.publication.place
Cambridge
en_US
ethz.publication.status
published
en_US
ethz.leitzahl
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02070 - Dep. Gesundheitswiss. und Technologie / Dep. of Health Sciences and Technology::02540 - Institut für Translationale Medizin / Institute of Translational Medicine::08827 - Goldhahn, Jörg (Tit.-Prof.)
en_US
ethz.leitzahl.certified
ETH Zürich::00002 - ETH Zürich::00012 - Lehre und Forschung::00007 - Departemente::02070 - Dep. Gesundheitswiss. und Technologie / Dep. of Health Sciences and Technology::02540 - Institut für Translationale Medizin / Institute of Translational Medicine::08827 - Goldhahn, Jörg (Tit.-Prof.)
ethz.date.deposited
2023-01-04T04:58:04Z
ethz.source
SCOPUS
ethz.eth
yes
en_US
ethz.availability
Metadata only
en_US
ethz.rosetta.installDate
2023-04-20T07:22:22Z
ethz.rosetta.lastUpdated
2023-04-20T07:22:22Z
ethz.rosetta.versionExported
true
ethz.COinS
ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.atitle=The%20dominant%20logic%20of%20Big%20Tech%20in%20healthcare%20and%20pharma&rft.jtitle=Drug%20Discovery%20Today&rft.date=2023-02&rft.volume=28&rft.issue=2&rft.spage=103457&rft.issn=1359-6446&1878-5832&rft.au=Schuhmacher,%20Alexander&Haefner,%20Naomi&Honsberg,%20Katharina&Goldhahn,%20J%C3%B6rg&Gassmann,%20Oliver&rft.genre=unknown&rft_id=info:doi/10.1016/j.drudis.2022.103457&
Files in this item
| Files | Size | Format | Open in viewer |
|---|---|---|---|
|
There are no files associated with this item. |
|||
Publication type
-
Other Journal Item [5563]